Adaptive Biotechnologies Corp. company information, Employees & Contact Information

Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025 Yahoo Finance

Nov. 5: Adaptive Biotechnologies to Report Third Quarter 2025 Results — Webcast available online Stock Titan

Adaptive Biotechnologies Corporation to Announce Second Quarter 2025 Financial Results on August 5, 2025 Quiver Quantitative

Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results GlobeNewswire

Adaptive Biotechnologies Reports Strong MRD Revenue Growth and Financial Results for 2024 Nasdaq

Leading Immune System Biotech Adaptive to Present at Morgan Stanley's Global Healthcare Conference Stock Titan

Adaptive Biotechnologies and NeoGenomics Partner to Expand GlobeNewswire

Adaptive Biotechnologies Sets Q2 Earnings Date: Key Financial Results Coming August 5 for Immune System Pioneer Stock Titan

Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access Microsoft Source

A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2 Frontiers

Adaptive Biotechnologies and Flatiron Health Collaborate to Integrate clonoSEQ® Test into OncoEMR® for Enhanced Blood Cancer Care Quiver Quantitative

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025 Yahoo Finance

Adaptive Biotechnologies Receives Expanded Medicare GlobeNewswire

Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics Yahoo Finance

Adaptive Biotechnologies Hits Major Milestone: MRD Business Turns Profitable with 42% Revenue Jump Stock Titan

New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern Yahoo Finance

Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19 Amgen

Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal Residual Disease with clonoSEQ® Assay Across its Hematology and Oncology Portfolio Yahoo Finance

Adaptive Biotechnologies Announces Non-Dilutive Royalty Financing with OrbiMed for Up to $250 Million GlobeNewswire

Adaptive Biotechnologies Appoints Tycho Peterson As CFO citybiz

Self-Reported Use of COVID-19 Immunologic Test Results to Inform Decisions About Daily Activities and COVID-19 Vaccination medRxiv

Adaptive's clonoSEQ Test Secures Strong $2,007 Medicare Reimbursement Rate for 2025 Stock Titan

Adaptive Biotech hires Goldman Sachs to explore ‘strategic alternatives’ for key business lines GeekWire

Analysis of thymic generation of shared T‐cell receptor α repertoire associated with recognition of tumor antigens shows no preference for neoantigens over wild‐type antigens - Mattila - 2023 - Cancer Medicine Wiley Online Library

Check out Adaptive Biotechnologies Corp's stock price (ADPT) in real time CNBC

Resolving SARS-CoV-2 CD4+ T cell specificity via reverse epitope discovery ScienceDirect.com

Immunosequencing of the T-Cell Receptor Repertoire Reveals Signatures Specific for Identification and Characterization of Early Lyme Disease medRxiv

Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients PNAS

Early prediction of outcomes in DLBCL clinical trials through MRD testing Endpoints News

Adaptive Biotech pushes ahead with new Seattle HQ, showing strength of life sciences industry GeekWire

Response to Hypomethylating Agents in Myelodysplastic Syndrome Is Associated With Emergence of Novel TCR Clonotypes Frontiers

Adaptive Biotech's deal with Amgen influenced by belief that COVID-19 may return seasonally, like flu GeekWire

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results The Manila Times

HLA autoimmune risk alleles restrict the hypervariable region of T cell receptors medRxiv

Microsoft partners with Adaptive Biotech on AI-driven blood test to diagnose dozens of diseases at once GeekWire

T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire PNAS